Cinnamtannin B-1

CAS No. 88082-60-4

Cinnamtannin B-1( Cinnamtannin B1 | LDN-0022358 | LDN 0022358 | LDN0022358 | Cinnamtannin B1 (constituent of cinnamomum verum bark) )

Catalog No. M27809 CAS No. 88082-60-4

Cinnamtannin B1 is an A-type proanthocyanidin contained in several plant species such as Vaccinium vitis-idaea, Laurus nobilis L., Cinnamomum zeylanicum, and Lindera umbellata.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 202 In Stock
10MG 326 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cinnamtannin B-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Cinnamtannin B1 is an A-type proanthocyanidin contained in several plant species such as Vaccinium vitis-idaea, Laurus nobilis L., Cinnamomum zeylanicum, and Lindera umbellata.
  • Description
    Cinnamtannin B1 is an A-type proanthocyanidin contained in several plant species such as Vaccinium vitis-idaea, Laurus nobilis L., Cinnamomum zeylanicum, and Lindera umbellata. It is a potent antioxidant and protective agent against oxidative stress and apoptosis in human platelets. It is a Cox-2 inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Cinnamtannin B1 | LDN-0022358 | LDN 0022358 | LDN0022358 | Cinnamtannin B1 (constituent of cinnamomum verum bark)
  • Pathway
    Others
  • Target
    Antioxidant
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    88082-60-4
  • Formula Weight
    864.765
  • Molecular Formula
    C45H36O18
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (115.64 mM)
  • SMILES
    [H][C@@]12[C@@H](O)[C@@](Oc3cc(O)cc(O)c13)(Oc1cc(O)c3[C@@H]([C@@H](O)[C@H](Oc3c21)c1ccc(O)c(O)c1)c1c(O)cc(O)c2C[C@@H](O)[C@H](Oc12)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.G?rn M, et al. A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC). Onkologie. 2008 Apr;31(4):185-9.
molnova catalog
related products
  • NSC 191412

    NSC 191412 is an active compound.

  • ?-pBrPh-Glc

    ?-pBrPh-Glc (?pBrPhGlc) is an inhibitor of ice recrystallization, controlling the growth of extracellular ice and inhibiting the recrystallization of intracellular ice.

  • Nelonemdaz

    Nelonemdaz (Neu2000) is an NMDA receptor antagonist with antioxidant activity and neuroprotective activity used in the study of cerebral infarction reperfusion injury and acute ischemic stroke.